Company Filing History:
Years Active: 2019-2021
Title: Poornima Shetty: Innovator in Neuropharmacology
Introduction
Poornima Shetty is a distinguished inventor based in Bengaluru, India. She has made significant contributions to neuropharmacology, holding a total of four patents. Her innovative work focuses on the development of selective NR2B antagonists, which are essential in treating various central nervous system disorders.
Latest Patents
Among her notable patents are two related to selective NR2B antagonists. The first patent discloses compounds of formula I, including their salts, and discusses the use of these compounds as ligands for the NR2B receptor. This innovation signifies a crucial advancement in the treatment of disorders affecting the central nervous system. The second patent similarly provides compounds of Formula (I) and their pharmaceutically acceptable salts, reaffirming their role as ligands for the NR2B N-Methyl-D-aspartate (NMDA) receptor, underscoring their potential therapeutic applications.
Career Highlights
Currently, Poornima is affiliated with Bristol Myers Squibb Company, where she continues to push the boundaries of pharmaceutical research and development. Her innovative spirit and dedication to science have positioned her as a respected figure in her field.
Collaborations
In her career, Poornima has had the opportunity to collaborate with esteemed colleagues such as Imadul Islam and Srinivasan Thangathirupathy. These collaborations have undoubtedly enriched her research experience and have contributed to her inventive journey.
Conclusion
Poornima Shetty's work illustrates the potential impact of innovative pharmaceutical research on global health. Her patents on selective NR2B antagonists reflect her commitment to finding solutions for complex neurological disorders, paving the way for new treatment options in the field.